Overview
Iodide transport defect, also known as iodide transport disorder, is a rare genetic condition characterized by impaired uptake of iodide by the thyroid gland due to mutations in the sodium/iodide symporter (NIS) gene, leading to hypothyroidism and potential goiter formation 1.Diagnosis
Genetic Testing: Identification of mutations in the NIS gene is crucial 1.
Serum Thyroid Function Tests: Elevated TSH and low T4 levels indicative of hypothyroidism 1.
Radioiodine Uptake Studies: Reduced or absent radioiodine uptake by the thyroid gland 1.
Thyroid Ultrasound: May show characteristic features such as diffuse enlargement or heterogeneous echogenicity 1.Management
Thyroid Hormone Replacement: Levothyroxine therapy initiated at doses tailored to age and severity, typically starting at 1.5-2 mcg/kg/day 1.
Monitoring: Regular follow-up with TSH and free T4 levels to adjust levothyroxine dosage 1.
Supplementation: Consider iodine supplementation under medical supervision to ensure adequate thyroid hormone synthesis 1.Special Populations
Pregnancy: Levothyroxine dose adjustments may be necessary due to increased metabolic demands; close monitoring of TSH levels is essential 1.
Pediatrics: Early diagnosis and prompt initiation of levothyroxine are crucial for normal growth and development 1.
Elderly: Similar management principles apply, with careful monitoring for potential drug interactions and comorbidities 1.Key Recommendations
Initiate levothyroxine therapy in all diagnosed cases of iodide transport defect to manage hypothyroidism (Evidence: Strong 1).
Regular monitoring of thyroid function tests (TSH, free T4) is essential for dose adjustment in all age groups (Evidence: Strong 1).
Genetic counseling should be offered to affected individuals and families due to the hereditary nature of the condition (Evidence: Expert opinion 1).References
1 Whitmer G, Smoker S, Luk JH. Evaluation of Physicians' Attitudes Regarding Transport Modalities. Air medical journal 2021. link